benzimidazole has been researched along with ruthenium in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, ML; Cui, Y; Mo, HJ; Niu, YL; Wang, K; Ye, BH; Zhong, YR | 1 |
| Dennany, L; Forster, RJ; Griffith, D; Keyes, TE; Moser, F; O'Reilly, EJ | 1 |
| Dixneuf, PH; Požgan, F; Toupet, L | 1 |
| Chen, T; Fan, C; Li, L; Wong, YS; Zheng, W | 1 |
| Bauroth, S; Beckert, R; Bräutigam, M; Dietzek, B; Heinemann, FW; Meyer-Ilse, J; Monczak, K; Pilz, TD; Popp, J; Rau, S; Rockstroh, N; Schmitt, M | 1 |
| Barnham, KJ; Donaire, A; Janiak, C; Kenche, VB; Liu, XM; Ruiz, J; Yellol, GS; Yellol, JG | 1 |
| Chen, T; Lai, H; Li, L; Zhao, Z; Zheng, W | 1 |
| Alejo Perez Henarejos, S; Alexander Segato, C; Gammelgaard, B; Lambert, IH; Ruiz, J; Stürup, S; Støving Dam, C; Tsolakou, T; Yellol, GS | 1 |
| Costa, PP; Fernandes, AF; Fonteles, MC; Lopes, LG; Nascimento, NR; Sá, DS; Silva, CD; Sousa, EH | 1 |
| Chi, KW; Elumalai, P; Jeong, YJ; Kang, SC; Kim, DH; Kim, H; Park, DW | 1 |
| Borkowski, A; Czerwonka, G; Cłapa, T; Dańczuk, M; Drabik, M; Gmiter, D; Guzy, A; Jabłońska-Wawrzycka, A; Kaca, W; Kowalczyk, P; Narożna, D; Rogala, P; Syczewski, M | 1 |
| Arion, VB; Prince, S; Rylands, LI; Smith, GS; Welsh, A | 1 |
| Ballester, FJ; Bautista, D; Ortega, E; Ruiz, J; Santana, MD | 1 |
| Peng, YB; Tan, CP; Tao, C; Zhao, P | 1 |
| Alexander, V; Prajith, NU; Priyanka, PV | 1 |
15 other study(ies) available for benzimidazole and ruthenium
| Article | Year |
|---|---|
Ruthenium(II) 2,2'-bibenzimidazole complex as a second-sphere receptor for anions interaction and colorimeter.
Topics: Anions; Benzimidazoles; Binding Sites; Color; Hydrogen Bonding; Organometallic Compounds; Ruthenium | 2008 |
Ground and excited state communication within a ruthenium containing benzimidazole metallopolymer.
Topics: Benzimidazoles; Electrons; Luminescent Measurements; Organometallic Compounds; Polymers; Ruthenium | 2011 |
Preparation of hexacoordinating benzimidazole containing ligand and hexakis(benzimidazole-ruthenium(II)) complex. Molecular structure of C6{CH2-(N-benzimidazole-RuCl2(p-cymene))}6.
Topics: Benzimidazoles; Carbonates; Coordination Complexes; Crystallography, X-Ray; Cymenes; Ligands; Molecular Conformation; Organometallic Compounds; Phosphites; Ruthenium | 2011 |
Ruthenium complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers.
Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Humans; Inhibitory Concentration 50; Organometallic Compounds; Ruthenium | 2012 |
Modified bibenzimidazole ligands as spectator ligands in photoactive molecular functional Ru-polypyridine units? Implications from spectroscopy.
Topics: Benzimidazoles; Ligands; Organometallic Compounds; Photochemical Processes; Pyridines; Quantum Theory; Ruthenium; Spectrum Analysis, Raman | 2014 |
Synthesis of 2-pyridyl-benzimidazole iridium(III), ruthenium(II), and platinum(II) complexes. study of the activity as inhibitors of amyloid-β aggregation and neurotoxicity evaluation.
Topics: Amyloid beta-Peptides; Animals; Benzimidazoles; Chemistry Techniques, Synthetic; Drug Design; Female; Iridium; Ligands; Mice; Models, Molecular; Molecular Conformation; Neurons; Organometallic Compounds; Peptide Fragments; Platinum; Pregnancy; Protein Multimerization; Protein Structure, Secondary; Ruthenium | 2015 |
Antiangiogenic ruthenium(ii) benzimidazole complexes, structure-based activation of distinct signaling pathways.
Topics: Angiogenesis Inhibitors; Animals; Benzimidazoles; Cell Cycle Checkpoints; Cell Movement; Chickens; Coordination Complexes; DNA Damage; Human Umbilical Vein Endothelial Cells; Male; Mice, Inbred C57BL; Models, Biological; Neovascularization, Physiologic; Ruthenium; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
In vitro characterization of a novel C,N-cyclometalated benzimidazole Ru(II) arene complex: stability, intracellular distribution and binding, effects on organic osmolyte homeostasis and induction of apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Female; Homeostasis; Humans; Mice; Ovarian Neoplasms; Ovary; Ruthenium; Taurine | 2015 |
Non-nitric oxide based metallovasodilators: synthesis, reactivity and biological studies.
Topics: 2,2'-Dipyridyl; Animals; Aorta; Aza Compounds; Benzimidazoles; Cell Line; Humans; Indazoles; Indoles; Organometallic Compounds; Quinolines; Rats; Ruthenium; Superoxides; Vasodilation; Vasodilator Agents | 2015 |
Antitumor and biological investigation of doubly cyclometalated ruthenium(II) organometallics derived from benzimidazolyl derivatives.
Topics: Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cytokines; Drug Screening Assays, Antitumor; Drug Stability; Humans; Ligands; Models, Molecular; Molecular Conformation; Organometallic Compounds; Ruthenium | 2016 |
A benzimidazole-based ruthenium(IV) complex inhibits Pseudomonas aeruginosa biofilm formation by interacting with siderophores and the cell envelope, and inducing oxidative stress.
Topics: Animals; Benzimidazoles; Binding Sites; Biofilms; Cattle; Cell Wall; Hydrophobic and Hydrophilic Interactions; Microscopy, Electron, Scanning; Models, Theoretical; Oligopeptides; Oxidative Stress; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Ruthenium; Serum Albumin, Bovine; Siderophores | 2019 |
Synthesis and antiproliferative activity of benzimidazole-based, trinuclear neutral cyclometallated and cationic, N
Topics: Antineoplastic Agents; Benzimidazoles; Cell Proliferation; Chelating Agents; Chemistry Techniques, Synthetic; Coordination Complexes; Humans; MCF-7 Cells; Models, Molecular; Molecular Conformation; Ruthenium | 2020 |
Ru(ii) photosensitizers competent for hypoxic cancers via green light activation.
Topics: Benzimidazoles; Coordination Complexes; HeLa Cells; Humans; Light; Photosensitizing Agents; Ruthenium; Tumor Hypoxia | 2020 |
Inhibition of Aβ peptide aggregation by ruthenium(II) polypyridyl complexes through copper chelation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzimidazoles; Cell Line, Tumor; Cell Survival; Chelating Agents; Coordination Complexes; Copper; Humans; Mitochondria; Neurons; Oxyquinoline; Protein Aggregates; Protein Aggregation, Pathological; Reactive Oxygen Species; Ruthenium | 2021 |
Synthesis, characterization, photophysical, lipophilicity, and in vitro fluorescence studies of mono-, di-, and trinuclear Ru(II) polypyridyl complexes of pyridinyl benzimidazole derivatives.
Topics: Benzimidazoles; Fluorescence; HeLa Cells; Humans; Ligands; Ruthenium | 2022 |